Net profit of Glenmark Pharmaceuticals reported to Rs 347.96 crore in the quarter ended December 2024 as against net loss of Rs 351.37 crore during the previous quarter ended December 2023. Sales rose 34.21% to Rs 3301.90 crore in the quarter ended December 2024 as against Rs 2460.29 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 3301.90 | 2460.29 | 34 |
| OPM % | 18.18 | -8.48 | - |
| PBDT | 579.06 | -297.58 | LP |
| PBT | 456.33 | -444.66 | LP |
| NP | 347.96 | -351.37 | LP |